Biolife Solutions (BLFS) Market Capitalization (2010 - 2026)

Biolife Solutions (BLFS) has reported Market Capitalization for 17 consecutive years, with $1.4 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 33.96% year-over-year to $1.4 billion in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 33.96% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, down 4.29% from the prior year.
• Market Capitalization was $1.4 billion for Q2 2026 at Biolife Solutions, up from $931.6 million in the prior quarter.
• Over five years, Market Capitalization peaked at $1.4 billion in Q2 2026 and troughed at $587.4 million in Q2 2022.
• A 5-year average of $976.1 million and a median of $966.9 million in 2022 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization sank 67.46% in 2022 and jumped 91.23% in 2024, its largest moves.
• Over 5 years, Market Capitalization stood at $779.5 million in 2022, then retreated by 5.85% to $734.0 million in 2023, then soared by 65.91% to $1.2 billion in 2024, then declined by 4.29% to $1.2 billion in 2025, then gained by 18.46% to $1.4 billion in 2026.
• The last three Market Capitalization figures came in at $1.4 billion (Q2 2026), $931.6 million (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.